Agmatine pretreatment protects retinal ganglion cells (RGC-5 cell line) from oxidative stress in vitro

Biocell

Volumn 32, Issue 3, 2008, Pages 245-250

  Yoko, Iizuka ^a   Hong, Samin ^b   Kim, Chan Yun ^b   Kim, Seung Kab ^b   Seong, Gong Je ^b  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Apoptosis; Neuronal damage; Neuroprotection

Indexed keywords

AGMATINE; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; ENZYME INHIBITORS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RATS; RETINAL GANGLION CELLS; STAUROSPORINE;

RATTUS;

EID: 58349094747     PISSN: 03279545     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Frassetto LJ, Schlieve CR, Lieven CJ, Utter AA, Jones MV, Agarwal N, Levin LA (2006). Kinase-dependent differentiation of a retinal ganglion cell precursor. Invest Ophthalmol Vis Sci. 47: 427-438.
2. Gilad GM, Gilad VH (2000). Accelerated functional recovery and neuroprotection by agmatine after spinal cord ischemia in rats. Neurosci Lett. 296: 97-100.
3. Gilad GM, Salame K, Rabey JM, Gilad VH (1996). Agmatine treatment is neuroprotective in rodent brain injury models. Life Sci. 58: PL41-46.
4. Grillo MA, Colombatto S (2004). Metabolism and function in animal tissues of agmatine, a biogenic amine formed from arginine. Amino Acids. 26: 3-8.
5. Harvey R, Chintala SK (2007). Inhibition of plasminogen activators attenuate the death of differentiated retinal ganglion cells and stabilized their neurite network in vitro. Invest Ophthalmol Vis Sci. 48: 1884-1891.
6. Hong S, Lee JE, Kim CY, Seong GJ (2007). Agmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell line. BMC Neurosci. 8: 81.
7. Kalapesi FB, Coroneo MT, Hill MA (2005). Human ganglion cells express the alpha-2 adrenergic receptor: relevance to neuroprotection. Br J Ophthalmol. 89: 758-763.
8. Kim DJ, Kim DI, Lee SK, Suh SH, Lee YJ, Kim J, Chung TS, Lee JE (2006). Protective effect of agmatine on a reperfusion model after transient cerebral ischemia: Temporal evolution on perfusion MR imaging and histopathologic findings. AJNR Am J Neuroradiol. 27: 780-785.
9. Kim JH, Yenari MA, Giffard RG, Cho SW, Park KA, Lee JE (2004). Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury. Exp Neurol. 189: 122-130.
10. Kotil K, Kuscuoglu U, Kirali M, Uzun H, Akcetin M, Bilge T (2006). Investigation of the dose-dependent neuroprotective effects of agmatine in experimental spinal cord injury: a prospective randomized and placebo-control trial. J Neurosurg Spine. 4: 392-399.
11. Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ (1994). Agmatine an endogenous clonidine-displacing substance in the brain. Science 263: 966-969.
12. Lievin CJ, Millet LE, Hoegger MJ, Levin LA (2007). Induction of axon and dendrite formation during early RGC-5 cell differentiation. Exp Eye Res. 85: 678-683.
13. Reis DJ, Regunathan S (2000). Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci. 21: 187-193.
14. Wang WP, Iyo AH, Miguel-Hidalgo J, Regunathan S, Zhu MY (2006). Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons. Brain Res. 1084: 210-216.
15. Yang XC, Reis DJ (1999). Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J Pharmacol Exp Ther. 288: 544-549.
16. Zhu MY, Piletz JE, Halaris A, Regunathan S (2003). Effect of agmatine against cell death induced by NMDA and glutamate in neurons and PC12 cells. Cell Mol Neurobiol. 23: 865-872.